RUNX1 and acute myeloid leukemia: RUNX1 in MDS. Several studies reported somatic mutations in RUNX1 in patients with primary MDS, therapy-related MDS (t-MDS), and AML from MDS progression [313,314,315,316,317,318,319,320].